Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Double-Crane Limin Pharmaceutical, a subsidiary of China Resources Double-Crane Pharmaceutical Co., Ltd., is a prominent Chinese pharmaceutical manufacturer based in Jinan. The company specializes in the production of high-quality generic drugs and active pharmaceutical ingredients (APIs) across several therapeutic areas, including cardiovascular health, anti-infectives, and endocrine disorders. Its product portfolio features well-known treatments for hypertension and hyperlipidemia, such as valsartan and atorvastatin. As part of the larger China Resources Group, the company leverages extensive manufacturing capabilities and a robust distribution network to serve the domestic Chinese market. The firm is committed to maintaining high GMP standards and advancing the accessibility of essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Resources Double-Crane Limin Pharmaceutical.